On ECHEMI
Home > Drugs > Dapagliflozin Registered Holders
Dapagliflozin structure

Dapagliflozin structure

Dapagliflozin

Dapagliflozin (BMS-512148) is a sodium-glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.

Find 82 Related Holders

Hunan Xianshi Pharmaceutical Co., Ltd.
China China

API Registration Country

API Inactive
  • Founded in:

    2021-05-20
  • Country:

    China China
  • Address:

    No. 19, Baizhu Road, Liuyang Economic and Technological Development Zone, Changsha City, Hunan Province
  • Tax NO.:

    91430181MA4TCN164D
  • Registered Funds:

    60 million yuan
  • Email:

Changchun HaiYue Pharmaceutical Limited By Share Ltd.
China China

API Registration Country

API Inactive
  • Founded in:

    1992-09-12
  • Country:

    China China
  • Address:

    No. 5555, Shuangying Road, Shuangyang Economic Development Zone, Shuangyang District, Changchun City
  • Tax NO.:

    912201016059030427
  • Registered Funds:

    226.1666 million yuan
  • Email:

Recommended Suppliers of Dapagliflozin
View 146 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.